Inovio Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (349)

Latest Posts

About This Stock More About This Stock
Market Briefing For Thursday, Dec. 23
Article By: Gene Inger
Thursday, December 23, 2021 3:05 AM EDT
'Fortune favors the brave' it is said; it's partially so in this market, where we certainly got the ignition Tuesday of the seasonal rebound we looked for and more on Wednesday.
In this article: MRK, PFE, INO, LWLG, AEHR Also: AMD, SRNE, LPTH, SPX
Read
Market Briefing For Monday, Apr. 26
Article By: Gene Inger
Monday, April 26, 2021 2:20 AM EDT
Nasdaq is perking up, primarily led by FANG types reporting next week (discounted). So, higher a bit near-term; then, risks.
In this article: JNJ, INO, SRNE, SPX, VIX, NYA
Read
Market Briefing For Thursday, Jan. 7
Article By: Gene Inger
Thursday, January 7, 2021 8:00 AM EDT
The market was strong on an insane day. Elsewhere people are frustrated, struggling, fatigued by the pandemic and by waiting for closure as regards the election.
In this article: INO, SRNE Also: LLY, REGN
Read
Market Briefing For Tuesday, Dec. 29
Article By: Gene Inger
Tuesday, December 29, 2020 3:32 AM EDT
Anxiety relief suffices to describe the market's response to the President's shift late Sunday, by signing the 'relief' bill, while lobbying for the $2000 check to each qualified individual anyway.
In this article: INO, SRNE, AAPL, LPTH, T Also: DIA, SPX
Read
Market Briefing For Monday, Dec. 28
Article By: Gene Inger
Saturday, December 26, 2020 11:00 PM EDT
Some are too sure stocks are the new bonds.
In this article: INO, SRNE, MRNA, SPX Also: AZN, PFE, JNK, TLT
Read

Latest Tweets for $INO

No tweets yet!

PARTNER HEADLINES

$INO

Week In Review: How Trump's Policies Moved Stocks - Sunday, May 10
Adam Reynolds 5/11/2020 12:20:40 PM

"When we look at the immune response that you can induce with a modest dose - one that's feasible to be translated into humans - and the amount of time it takes to get to that level of immunity, it is really quite impressive," Fauci was quoted as saying when discussing both Moderna's vaccine candidate and the one being developed at Oxford. "It is also really easy to scale up with these two, in the sense of making a lot of doses pretty quickly," he reportedly added."

$MRNA, $INO: The above quote is the only "proof" that has ever been offered by anyone connected with MRNA that their vaccine is safe and effective!

Bahhhhhhhh, Humbug

The Greatest Show On Earth - Not Really - It's Getting Ugly Dangerous
James Gornick 4/13/2020 2:01:48 AM

Always keep in mind, this article deals heavily with HIGH FREQUENCY TRADING ALGORITHMS PUSHING of Borrowing of massive amount of shares into the 10s of Millions too Billions in block succession hitting every Bid Order held within our Electronic Trading Exchanges, for purchase on the way down and just as quick in locking the profits in Buying back what they borrowed at. Much lower prices.

We have our ways of tracking these huge black swans!

The average investor or financial advisors can’t even stand a Chance in not providing true fiduciary protection for the many 401ks, Pensions, and institutional held corporate investments.

Just an update for making sure I have not left out, the truest engines of described recoiled that are at play and quite Ugly Dangerous as I stated in the title of the article.

The 150 million diluted shares of #Inovio $INO is actually a bold move in securing significant capital moving forward in bringing the final stages of the deep pipeline of truly Orphaned Levrls of Life Saving Vaccines, and medical cures for several highly held Virus of HPV affecting well over 80 million and counting as the lock downs of the world brings these whom are becoming infectious with HPV to even greater numbers.

Inovio Pharmaceuticals: 2020 Is The Make Or Break Year
Danielle Rogers 2/16/2020 3:32:53 AM

Good analysis on $INO.

5 Biotech Stocks Ready To Crush The Market In 2016
Peter Craig 1/12/2016 7:27:44 PM

It's great to see some positive coverage on $INO!

1 to 5 of 5 comments